{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T07:08:44Z","timestamp":1789456124739,"version":"build-2803163510"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Surg Int"],"DOI":"10.1007\/s00383-026-06641-x","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:19:20Z","timestamp":1789453160000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of primary tumor resection on survival in high-risk neuroblastoma: a long-term single-center study"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0010-4902","authenticated-orcid":false,"given":"Naonori","family":"Kawakubo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junnosuke","family":"Maniwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiro","family":"Toriigahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuhisa","family":"Fukuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Utako","family":"Oba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Yoshimaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouji","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiharu","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunari","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuro","family":"Tajiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"6641_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/01.cco.0000147901.12325.90","volume":"17","author":"MC Henry","year":"2005","unstructured":"Henry MC, Tashjian DB, Breuer CK (2005) Neuroblastoma update. Curr Opin Oncol 17:19\u201323","journal-title":"Curr Opin Oncol"},{"key":"6641_CR2","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrc1014","volume":"3","author":"GM Brodeur","year":"2003","unstructured":"Brodeur GM (2003) Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 3:203\u2013216","journal-title":"Nat Rev Cancer"},{"key":"6641_CR3","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/08880018.2017.1330375","volume":"34","author":"AA Ahmed","year":"2017","unstructured":"Ahmed AA, Zhang L, Reddivalla N et al (2017) Neuroblastoma in chidren: update on clinicopathologic and genetic prognostic factors. Pediatr Hematol Oncol 34:165\u2013185","journal-title":"Pediatr Hematol Oncol"},{"key":"6641_CR4","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1200\/JCO.2012.45.9339","volume":"31","author":"T Simon","year":"2013","unstructured":"Simon T, H\u00e4berle B, Hero B, von Schweinitz D, Berthold F (2013) Role of surgery in the treatment of patients with stage 4 neuroblastoma age 18 months or older at diagnosis. J Clin Oncol 31:752\u2013758. https:\/\/doi.org\/10.1200\/JCO.2012.45.9339","journal-title":"J Clin Oncol"},{"key":"6641_CR5","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1200\/JCO.19.03117","volume":"38","author":"K Holmes","year":"2020","unstructured":"Holmes K, Potschger U, Pearson ADJ, Sarnacki S, Cecchetto G, Gomez-Chacon J et al (2020) Influence of surgical excision on the survival of patients with stage 4 high-risk neuroblastoma: A report from the HR-NBL1\/SIOPEN study. J Clin Oncol 38:2902\u20132915. https:\/\/doi.org\/10.1200\/JCO.19.03117","journal-title":"J Clin Oncol"},{"key":"6641_CR6","doi-asserted-by":"publisher","first-page":"151338","DOI":"10.1016\/j.sempedsurg.2023.151338","volume":"32","author":"SA Shaffiey","year":"2023","unstructured":"Shaffiey SA, Le HD, Christison-Lagay E, Fialkowski EA, Aldrink JH, Grant CN et al (2023) Critical elements of pediatric neuroblastoma surgery. Semin Pediatr Surg 32:151338. https:\/\/doi.org\/10.1016\/j.sempedsurg.2023.151338","journal-title":"Semin Pediatr Surg"},{"key":"6641_CR7","doi-asserted-by":"publisher","first-page":"e575","DOI":"10.1097\/SLA.0000000000005163","volume":"275","author":"LE Matthyssens","year":"2022","unstructured":"Matthyssens LE, Nuchtern JG, Van De Ven CP, Gabra HOS, Bjornland K, Irtan S et al (2022) A novel standard for systematic reporting of neuroblastoma surgery: The International Neuroblastoma Surgical Report Form (INSRF). Ann Surg 275:e575\u2013e585. https:\/\/doi.org\/10.1097\/SLA.0000000000005163","journal-title":"Ann Surg"},{"key":"6641_CR8","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1097\/SLA.0b013e31826cbbbd","volume":"256","author":"JG Nuchtern","year":"2012","unstructured":"Nuchtern JG, London WB, Barnewolt CE, Naranjo A, McGrady PW, Geiger JD et al (2012) A prospective study of expectant observation as primary therapy for neuroblastoma in young infants: A Children\u2019s Oncology Group study. Ann Surg 256:573\u2013580. https:\/\/doi.org\/10.1097\/SLA.0b013e31826cbbbd","journal-title":"Ann Surg"},{"key":"6641_CR9","doi-asserted-by":"publisher","first-page":"e27914","DOI":"10.1002\/pbc.27914","volume":"66","author":"T Iehara","year":"2019","unstructured":"Iehara T, Yoneda A, Yokota I, Takahashi H, Teramukai S, Kamijyo T et al (2019) Results of a prospective clinical trial JN-L-10 using image-defined risk factors to inform surgical decisions for children with low-risk neuroblastoma disease: A report from the Japan Children\u2019s Cancer Group Neuroblastoma Committee. Pediatr Blood Cancer 66:e27914. https:\/\/doi.org\/10.1002\/pbc.27914","journal-title":"Pediatr Blood Cancer"},{"key":"6641_CR10","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1093\/jjco\/hyw050","volume":"46","author":"T Iehara","year":"2016","unstructured":"Iehara T, Yagyu S, Tsuchiya K, Kuwahara Y, Miyachi M, Tajiri T et al (2016) Residual tumor in cases of intermediate-risk neuroblastoma did not influence the prognosis. Jpn J Clin Oncol 46:661\u2013666. https:\/\/doi.org\/10.1093\/jjco\/hyw050","journal-title":"Jpn J Clin Oncol"},{"key":"6641_CR11","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12887-020-02061-5","volume":"20","author":"T Iehara","year":"2020","unstructured":"Iehara T, Yoneda A, Kikuta A, Muraji T, Tokiwa K, Takahashi H et al (2020) A phase II JN-I-10 efficacy study of IDRF-based surgical decisions and stepwise treatment intensification for patients with intermediate-risk neuroblastoma: A study protocol. BMC Pediatr 20:212. https:\/\/doi.org\/10.1186\/s12887-020-02061-5","journal-title":"BMC Pediatr"},{"key":"6641_CR12","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1200\/JCO.2016.67.2642","volume":"35","author":"D von Allmen","year":"2017","unstructured":"von Allmen D, Davidoff AM, London WB, Van Ryn C, Haas-Kogan D, Kreissman SG et al (2017) Impact of extent of resection on local control and survival in patients from the COG A3973 study with high-risk neuroblastoma. J Clin Oncol 35:208\u2013216. https:\/\/doi.org\/10.1200\/JCO.2016.67.2642","journal-title":"J Clin Oncol"},{"key":"6641_CR13","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00595-011-0053-0","volume":"42","author":"T Tajiri","year":"2012","unstructured":"Tajiri T, Souzaki R, Kinoshita Y, Koga Y, Suminoe A, Hara T et al (2012) Implications of surgical intervention in the treatment of neuroblastomas: 20-year experience of a single institution. Surg Today 42:431\u2013438. https:\/\/doi.org\/10.1007\/s00595-011-0053-0","journal-title":"Surg Today"},{"key":"6641_CR14","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s10147-018-1281-8","volume":"23","author":"T Hishiki","year":"2018","unstructured":"Hishiki T, Matsumoto K, Ohira M, Kamijo T, Shichino H, Kuroda T et al (2018) Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG). Int J Clin Oncol 23:965\u2013973. https:\/\/doi.org\/10.1007\/s10147-018-1281-8","journal-title":"Int J Clin Oncol"},{"key":"6641_CR15","doi-asserted-by":"publisher","first-page":"e30976","DOI":"10.1002\/pbc.30976","volume":"71","author":"A Yoneda","year":"2024","unstructured":"Yoneda A, Shichino H, Hishiki T, Matsumoto K, Ohira M, Kamijo T et al (2024) A nationwide phase II study of delayed local treatment for children with high-risk neuroblastoma: The Japan Children\u2019s Cancer Group Neuroblastoma Committee Trial JN-H-11. Pediatr Blood Cancer 71:e30976. https:\/\/doi.org\/10.1002\/pbc.30976","journal-title":"Pediatr Blood Cancer"}],"container-title":["Pediatric Surgery International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00383-026-06641-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00383-026-06641-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00383-026-06641-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:19:21Z","timestamp":1789453161000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00383-026-06641-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6641"],"URL":"https:\/\/doi.org\/10.1007\/s00383-026-06641-x","relation":{},"ISSN":["1437-9813"],"issn-type":[{"value":"1437-9813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"assertion":[{"value":"26 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no competing economic interests to report.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"407"}}